Monday, October 7th, 2013
In July 2013, pharmaphorum filmed a round table debate, sponsored by AstraZeneca, to discuss the topic of ‘Oncology shaping the future of personalised healthcare’. Here, both video and written media outputs can be found, covering both the full debate and individual interviews with the expert participants.
Posted in pharma7 | Comments Off on Oncology shaping the future of personalised healthcare media hub
Thursday, October 3rd, 2013
Recent data from the Pew Internet and American Life project found that 8 in 10 online health inquiries start at a search engine like Google, a number that hasn’t changed since 2000. But medical information from a search engine is often incomplete or untrustworthy, and isn’t always enough information to answer specific questions. At the Health 2.0 event in Santa Clara, California this week, several creators of online patient communities talked about their approaches to connecting patients with health information online.
Posted in pharma7 | Comments Off on Online patient platforms vie to one-up “Dr. Google”
Wednesday, October 2nd, 2013
As pharmaphorum publishes its first round table video debate, sponsored by AstraZeneca on the topic of personalised healthcare, Paul Tunnah reviews some key themes to emerge from the discussion with regards to oncology and beyond.
Posted in pharma7 | Comments Off on Collaboration drives the future of personalised healthcare
Monday, September 30th, 2013
Criminologists have also claimed that tablets and smart phones are responsible for the recent falls in crime rates, as bored teenagers now actually do have better things to do with their time. But what of our industry? While it’s true that pharma has embraced tablets, it is worth asking whether they have had the same transformational impact on the humble detail. In short what have iPads ever done for pharma?
Posted in pharma7 | Comments Off on What did the iPad ever do for us?
Friday, September 27th, 2013
Adobe is out with their survey of 1000 marketers within the US and their key finding ? The marketing profession has changed dramatically as 76% of marketers think marketing has changed more in the past two years than the past 50. While some pharma companies have made significant changes in their marketing the majority, in my opinion, have not. The decision to allocate more money into digital is not the answer to outdated marketing. The answer lies in both the ability to attract new talent and the willingness to change processes that add little value to marketing or customers.
Posted in pharma7 | Comments Off on Marketing has changed significantly but in pharma….?
Wednesday, September 25th, 2013
Pfizer has begun using digital drug representatives to market medicines, leaving the decision as to whether they want to see them in doctors’ hands.
Posted in pharma7 | Comments Off on Pfizer begins using ‘digital’ reps
Thursday, September 12th, 2013
The global wireless health market is currently valued at $23.8 billion in 2013 and is expected to reach $59.7 billion by 2018, at an estimated CAGR of 20.2% from 2013 to 2018, according to a new report by MarketsandMarkets.
Posted in pharma7 | Comments Off on Global Wireless Health Market Expected To Reach $59.7 billion by 2018
Wednesday, September 4th, 2013
Agency Saatchi & Saatchi Health has relaunched a Roche website focused on colon cancer in Spain. Replacing a site first launched a decade ago, the relaunched cancercolon.es has a two-fold objective: to provide information for the scientific community and to act as an online meeting place for sufferers of colorectal cancer.
Posted in pharma7 | Comments Off on Saatchi & Saatchi Health relaunches Roche’s cancer website
Friday, August 9th, 2013
The EU’s Innovative Medicines Initiative (IMI) is aiming to revolutionize pharmacovigilance by funding the development of a framework for detecting adverse events (AEs) mentioned on social media.
Posted in pharma7 | Comments Off on IMI Call for Social Media Detection of Adverse Events
Friday, August 9th, 2013
Posted in pharma7 | Comments Off on Mobile technology drives timely and more efficient dementia diagnosis
You are currently browsing the archives for the pharma7 category.
